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Introduction. Epidemiological and biological arguments put 
papillomavirus infection (HPV) as a determining factor in the 
etiology of cervical cancer. The main objective of this study is 
to assess the knowledge, attitudes and practices related to HPV 
prevention and cervical cancer screening among women living in 
the city of Sousse, Tunisia.
Methods. Five hundred Tunisian women were interviewed face to 
face between May and June 2016. The questionnaire consisted in 
14 questions relating participants’ socio-demographic informa-
tion, their awareness level, attitudes and practices regarding HPV 
and cervical cancer, including their understanding of the underly-
ing cervical cancer etiology and preventive actions such as the 
Pap Smear test, and finally their acceptability and willingness to 
receive the anti-HPV vaccine under certain circumstances. Mul-
tivariate analyses were conducted to identify predictive factors of 
good acceptability of cervical cancer prevention methods. 
Results. Four hundred fifty-two questionnaires were completed 
and included in the analysis. The awareness of a sexually trans-
mitted infection as an etiological agent for cervical cancer was 
expressed by 175 (38.7%) participants, the correct finality of the 
Pap Smear test by 308 (68%) and its recommended frequency by 
176 (38.9%) respondents. Among all participants, 125 (27.7%) 
had undertaken the Pap Smear test at least once in their lifetime, 
363 (80.3%) were interested in receiving the anti-HPV vaccine 
for themselves, 387 (86%) for their daughters and 405 (90%) 
approved the introduction of the anti-HPV vaccine in the Tunisian 
national program of vaccination.
Conclusions. The knowledge and awareness of HPV infection and 
cervical cancer among Tunisian women was found to be moderate 
(around 40%) and the acceptability of the anti-HPV vaccine was 
found to be high (over 80%). These results are concordant with 
the results of other studies conducted in other MENA countries.
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Introduction
Given the conservative cultural context of the Middle 
East - North Africa (MENA), the prevalence of sexually 
transmitted infections (including human papillomavirus 
[HPV]) has previously been reported to be low in this 
specific region compared to the rest of the world  [1]. 
Knowing this context, and given the rapid changes in the 
lifestyle induced by globalization, sexual behavior, espe-
cially among younger generations, is changing towards 
more liberal practices compared to the previous decades. 
These changes may induce an increase of the prevalence 
of sexually transmitted diseases among youth population 
of the MENA region [2]. 
Knowing the scientifically proved etiologic link between 
HPV infection and cervical cancer, similar findings were 
reported regarding the cervical cancer incidence in this 
area [3, 4].
However, despite the current relatively low incidence 
rates, cervical cancer is considered a public health issue 
in the MENA region [5]. This fact may be explained by 
the lack of governmental willing to establish a national 
cervical cancer prevention program in the MENA region 
and to include the anti-HPV vaccine within national vac-
cination programs [5]. This position has often been justi-
fied by cultural and religious sensitivities that may limit 
the success of sexually behavior related vaccination such 
as the anti-HPV vaccine [6].
That said, several studies investigated the acceptability 
of the anti-HPV vaccine in various MENA countries 
(Lebanon, Iran, Morocco, Saudi Arabia, Turkey, etc). 
These studies showed that despite the low level of HPV 
and cervical cancer knowledge among women in this 
area  [7-10], all findings revealed moderate to high ac-
ceptability of the anti-HPV vaccine  [11-14]. Since no 
study has been yet focusing on the specific case of Tu-
nisia, we conducted the current study to assess whether 
trends reported for the rest of the region were also valid 
in the Tunisian context. These results would be useful 
for the design of an efficient and effective Tunisian na-
tional anti-HPV vaccination program.
Methods
This cross-sectional study involved the administration 
of 500 questionnaires to randomly selected women from 
different age groups in the general population of the city 
of Sousse, Tunisia. The questionnaires were administered 
through direct interview of patients visiting outpatient 
clinics in “Farhat Hached Hospital” or visiting the wait-
ing area of the National Health Insurance Fund - CNAM 
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(la Caisse Nationale de l’Assurance Maladie) between 
May and June 2016. Participants answered a question-
naire that assessed their knowledge, attitudes and prac-
tices regarding HPV and cervical cancer screening.
The designed questionnaire is semi-structured and com-
posed of 14 questions. The first 4 questions gather socio-
demographic information of the participants (age, pro-
fessional activity, marital status, health sector). The next 
6 questions assess participants’ knowledge, attitudes and 
practices regarding HPV and cervical cancer, including 
their understanding of the underlying cervical cancer eti-
ology and preventive actions such as the Pap smear test. 
Finally, the last 4 questions assess the acceptability and 
willingness of participants to receive the anti-HPV vac-
cine under certain circumstances.
All respondents were informed of the voluntary and 
anonymous nature of the study. A research assistant as-
sisted each of the participants when filling the question-
naire to make sure that all the questions were well-un-
derstood. Fully completed questionnaires were obtained 
from 452 respondents, representing a final participating 
rate of 90.4% of our conventional sample.
Statistical analysis
Data was entered to the computer software Statistical 
Package for Social Sciences (SPSS Inc., Chicago, IL., 
USA) version 20 for the purpose of analysis. 
Descriptive statistics were reported using mean ± stand-
ard deviation (SD) for participants’ age, frequency and 
percentage for all the rest categorical variables. 
In addition to the descriptive analysis, multivariate ana-
lyzes were conducted to assess the association between 
participants’ demographics (age, work status, marital 
status, and health sector) and the Pap Smear test history, 
then second the acceptability of the anti-HPV vaccine. 
The acceptability of the vaccine was assessed through 
several proxies such as the willingness to receive the 
vaccine, the willingness to get daughter vaccinated and 
being favourable to the inclusion of the anti-HPV vac-
cine in the Tunisian national vaccination program. Mul-
tivariate logistic regression analyses were performed for 
the following associations:
• the association between main participants’ demo-
graphics [age (continuous), marital status (categori-
cal: single/married/divorced or widow), professional 
status (categorical: none/employee/student) and 
health sector (categorical: private/public/private and 
public)] as independent variables and the Pap Smear 
test history as the dependent variable (categorical: 
yes/no);
• the associations between Pap Smear test history (cat-
egorical: yes/no) and main participants’ demograph-
ics [age (continuous), marital status (categorical: sin-
gle/married/divorced or widow), professional status 
(categorical: none/employee/student) and health sec-
tor (categorical: private/public/private and public)] 
as independent variables and a) the awareness of the 
existence of an anti-HPV vaccine, b) the interest in 
receiving the vaccine, c) the interest in giving the 
anti-HPV vaccine to daughters and d) the accept-
ability of including the anti-HPV vaccine within the 
national vaccination program as dependent variables 
(categorical: yes / no);
• logistic analyses results are presented in Table I and 
all association with statistical p-values of less than 
0.05 were considered as significant.
Results
The results are grouped under first socio-demographic 
data, second the participants’ knowledge and awareness 
level, third the acceptability of cervical cancer preven-
tion methods and finally the associations between par-
ticipants sociodemographic determinants and proxies of 
the acceptability of cervical cancer prevention methods. 
Participants’ socio-demographic profile
452 completed questionnaires were suitable for analy-
sis. The respondents consisted in Tunisian women with 
an overall mean age of 30.8 years old (± SD 6.9 years), 
ranging between 18 and 62 years old. 
Among the 452 participants, 193 (43%) were single, 
242 (53%) married and 17 (4%) divorced or widow. Two 
hundred and sixty-three (58%) respondents were profes-
sionally active, 115 (25%) students and 74 (16%) house-
wives. Three hundred and thirty-one (73 %) participants 
usually consulted in the private sector, 99 (22%) in the 
public sector and the remaining 22 (5%) participants de-
clared consulting in both sectors. The demographic in-
formation is shown in Table II.
Participants’ knowledge and awareness 
regarding cervical cancer  
prevention methods
The awareness of the Pap Smear test recommended 
frequency, cervical cancer risk factors, HPV infection 
spread ways and the awareness of the existence of an 
anti-HPV vaccine are shown in Table III.
Only 125 (28%) respondents had already received the 
Pap Smear test at least once in their lifetime and 188 
(42%) were aware of existence of the anti-HPV vaccine. 
Regarding the recommended frequency of Pap smear 
test, 176 (39%) women were aware that the correct fre-
quency is 3 to 5 years. 
With regards to the Pap smear test finality, 109 (24%) 
participants declared knowing or assuming that it is for 
sexually transmitted infections screening, 308 (68%) for 
cervical cancer screening, 7 (2%) for cervical cancer 
treatment and 93 (21%) women declared having no idea. 
Concerning the cervical cancer risk factors, the “genetic 
dimension” was selected by 227 (50%), “sexually trans-
mitted infection” by 175 (39%), “multiple partners” by 
146 (35%), “partner having multiples partners” by 107 
(24%), “immunity issues” by 153 (34%), “smoking” by 
125 (28%), “no idea” by 69 (15%) women among all the 
participants. 
Regarding the HPV spread ways, the correct options are: 
“unprotected sex” selected by 242 (54%), “protected 
sex” selected by 5 (1%) participants. Regarding incor-
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rect options, “blood” was selected by 71 (16%), “public 
toilets” by 69 (15%) women and 157 (35%) participants 
reporting having no idea. 
Participants’ acceptability of  
cervical cancer prevention methods
Concerning the willingness to receive the anti-HPV vac-
cine, the results are presented in Table  III: 363 (80%) 
participants were or would be interested in receiving the 
anti-HPV vaccine if recommended by their doctors, 387 
(86%) were or would be interested in giving their (fu-
ture) girl the anti-HPV vaccine if recommended by their 
doctors, and finally 405 (90%) were favourable to the 
inclusion of the anti-HPV vaccine in the national vac-
cine program as it would be free and systematic for all 
Tunisian girls.
Associations between participants  
socio-demographic determinants and proxies 
of the acceptability of cervical cancer 
prevention methods
Multivariate logistic regression analyses results present-
ed in Table I are showing statistically significant associa-
tions between Pap Smear test history and the four con-
sidered demographics: age 1.10 CI (1.06-1.15), working 
status 0.63 CI (0.40-0.98), marital status 4.37 CI (2.43-
7.86) and the health sector 1.93 CI (1.10-3.41). However, 
a unique statistically significant association was found 
between the awareness of the existence of an anti-HPV 
vaccine and the health sector 2.30  CI (1.02-5.20). No 
further statistically significant associations were found 
between participants’ demographics and the interest in 
receiving the vaccine, giving it to daughters or includ-
ing the anti-HPV vaccine within the national vaccination 
program.
Discussion
Cervical cancer is a preventable disease and one of the 
key aspects of its prevention is the early detection of 
the premalignant lesion through the cervical screening 
or by the anti-HPV vaccine prior to any sexual relation-
ships. 
Major findings of the present study showed that 28% of 
the respondents had already received the Pap smear test 
at least once during their lifetime. This result is concord-
ant with Hammas-Hlaili study that revealed that 22.6% 
(17.6-27.6) of the women from east-center of Tunisia 
had already received the Pap smear test at least once in a 
lifetime [15]. However, these results are not valid for es-
Tab. I. Analysis of association between demographics and acceptability of Pap Smear test and anti-HPV vaccine.
Age Work  
status
Health  
sector
Marital  
status
Pap Smear  
test history
OR-IC  
(95%)
P-value OR-IC  
(95%)
P-value OR-IC  
(95%)
P-value OR-IC  
(95%)
P-value OR-IC  
(95%)
P-value
Pap Smear  
test history
1.10 
(1.06-1.15)
0.00
0.63  
(0.40-0.98)
0.04
1.93  
(1.10-3.40)
0.22
4.37  
(2.43-7.86)
0.00 - -
Aware of the 
existence of 
the anti-HPV 
vaccine
0.96  
(0.89-1.03)
0.25
0.69  
(0.35-1.34)
0.27
2.30  
(1.02-5.20)
0.04
0.94  
(0.40-2.20)
0.89
0.58  
(0.24-1.42)
0.24
Interested 
in receiving 
the anti-HPV 
vaccine
0.99  
(0.95- 1.03)
0.54
1.03  
(0.68-1.57)
0.89
0.97  
(0.60- 
1.56)
0.89
0.94  
(0.56-1.60)
0.83
0.67  
(0.36-1.25)
0.21
Interested in 
giving the anti-
HPV vaccine to 
their daughters
0.99  
(0.94-1.03)
0.62
0.83  
(0.51-1.34)
0.44
1.40  
(0.81-2.41)
0.23
0.85  
(0.46-1.56)
0.60
1.04  
(0.53-2.04)
0.91
Interested 
in including 
the anti-HPV 
vaccine within 
the vaccination 
national 
program
0.98  
(0.93-1.04)
0.51
1.01  
(0.59-1.75)
0.96
0.94  
(0.51-1.73)
0.84
1.22  
(0.61-2.46)
0.57
0.49  
(0.20-1.19)
0.12
Tab. II. Socio-demographic information.
Total sample (452) %
Profession
None 74 16,4%
Employee 263 58,2%
Student 115 25,4%
Health sector
Private 331 73,2%
Public 99 21,9%
Private and public 22 4,9%
Marital status
Single 193 42,7%
Married 242 53,5%
Divorced/Widow 17 3,8%
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pecially the rural region of Tunisia where only between 
11% and 13% had received the Pap smear test [15].
This study also revealed some concerning findings: 
first, regarding cervical cancer risk factors, less than the 
half of all participants identified sexually transmitted 
infections as a risk factor for cervical cancer. Second, 
regarding HPV spread ways, participants were not prop-
erly aware especially of the possibility of HPV spread 
through unprotected as much as through protected sex. 
Third, regarding the recommended frequency of the 
screening, we notice that 20% of participants reported 
having no idea about the recommended periodicity. All 
these results represent real opportunities for improving 
HPV and cervical cancer awareness among Tunisian 
women and confirm findings reported in other studies 
regarding the low to moderate knowledge level about 
HPV infection and prevention from the cervical cancer. 
Regarding the acceptability of the anti-HPV vaccine, 
participants were highly willing to receive the anti-
HPV vaccine if it was relevant for them and to agree 
that their daughters or future daughters receive it. They 
were also extremely favourable (> 90%) to the inclu-
sion of the anti-HPV vaccine in the national vaccina-
tion program in order to make it systematic and free for 
all Tunisian girls. This finding also confirms the trend 
reported throughout the region of moderate to high ac-
ceptability of the HPV vaccine among women in the 
region despite the low level of knowledge about HPV 
and cervical cancer [16].
Regarding the assessment of the association between 
participants demographics and the acceptability of cer-
vical cancer prevention methods, results showed that 
history of Pap Smear test is statistically associated to 
participants’ working status, health sector in which par-
ticipants are used to consult and their marital status. 
However, these associations were not valid for the ac-
ceptability of anti-HPV vaccine. These results can be 
explained by the fact the anti-HPV vaccine is relatively 
new in comparison to the Pap Smear; therefore, women 
from all ranges of demographics are still much less in-
formed and sensitive to this primary prevention method. 
This situation may explain the absence of trends or sta-
tistically associations between participants demograph-
ics and the proxy variables of the acceptability of the 
anti-HPV vaccination. 
Tab. III. Level of Cervical Cancer and HPV knowledge and anti-HPV vaccine acceptability among respondents.
Total sample 
(452)
%
Pap Smear test history 125 27.7
Cervical cancer risk factors
Genetics 227 50.2
Viral infection 175 38.7
Multiple sexual partners 156 34.5
Partner had multiples sexual partners 107 23.7
Immune system issues 153 33.8
Smoking 125 27.7
No idea 69 15.3
Pap Smear test finality
Sexually transmitted infection screening (false) 109 24.1
Cervical cancer screening 308 68.1
Cervical cancer treatment (false) 7 1.5
No idea 93 20.6
Recommended Pap Smear test frequency
Annual (false) 185 40.9
Every 3 to 5 yeas 176 38.9
Every 10 years (false) 1 0.2
No idea 90 19.9
Routes of HPV spread
Unprotected sex 242 53.5
Protected sex 5 1.1
Blood (false) 71 15.7
Public toilets (false) 69 15.3
No idea 157 34.7
Already heard about anti-HPV vaccine 188 41.6
(Would be) interested in receiving anti-HPV vaccine if suggested by their doctor 363 80.3
Favourable to the administration of the anti-HPV vaccine to their (future) daughters 
if suggested by the doctor
387 85.6
Supports the introduction of anti-HPV vaccine in the national immunization program 
(systematic and free)
405 89.6
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Limitations
This study is the first in Tunisia to analyze the aware-
ness and acceptability of Tunisian women of two pre-
vention methods of cervical cancer. Among the main 
limitations of this study, we first mention the potential 
recall bias: women may not accurately recall if yes or 
no they undertook a Pap Smear test. The second limi-
tation of the study is the potential selection bias as-
sociated to the participants’ selection that included 
women only from care centers or healthcare adminis-
trative services; this selection of a non-representative 
conventional sample may limit the external validity 
of the study and the generalizability of our findings to 
the rest of Tunisian women. Finally, a final limitation 
of this study is the potential bias of social desirability 
since women responses may not reflect the reality of 
their opinions and may be formulated in a way to not 
be judged by the interviewer.
Conclusions
In conclusion, the knowledge and awareness levels of 
cervical cancer prevention methods through screening 
and anti-HPV vaccination among Tunisian women are 
similar to the trend found in other MENA countries. 
However, these levels are considered low compared to 
developed countries. Therefore, a national cervical can-
cer prevention program is still needed to be implemented 
in Tunisia. In this sense, regional cervical screening and 
inclusion of the anti-HPV vaccine in the national vac-
cination program should be encouraged. All involved 
health care professionals (gynaecologists, nurses, mid-
wives etc.) should benefit from educational initiatives in 
order to contribute to the enhancement of the usage of 
cervical cancer prevention methods available for Tuni-
sian women.
In addition to that, it is important to promote awareness 
among women with risk factors of cervical cancer, to 
emphasize the importance of Pap smear test on a regu-
lar basis and to guarantee them adequate follow-up and 
emotional support when needed. It is also important to 
sensitize parents about the advantages the anti-HPV 
vaccine would give to their daughters and to reassure 
them about the vaccination safety. These are all urgent 
measures essential to undertake in order to reduce mor-
bidity and mortality associated to cervical cancer in 
Tunisia.
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